{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:58:13Z","timestamp":1792180693941,"version":"4.4.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00347286"],"award-info":[{"award-number":["RS-2024-00347286"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vaccine.2025.127243","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:54:12Z","timestamp":1747036452000},"page":"127243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A comprehensive analysis of the current strategy for developing live attenuated vaccines against African swine fever: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Eurade","family":"Ntakiyisumba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryum","family":"Tanveer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayeon","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virusres.2012.11.009","article-title":"Cellular immunity in ASFV responses","volume":"173","author":"Takamatsu","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127243_bb0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0368-1742(21)80031-4","article-title":"On a form of swine fever occurring in British East Africa (Kenya Colony)","volume":"34","author":"Montgomery","year":"1921","journal-title":"J Comparat Pathol Therapeut"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/v11040310","article-title":"African swine fever status in Europe","volume":"11","author":"Cwynar","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127243_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40813-015-0013-y","article-title":"African swine fever: a global view of the current challenge","volume":"1","author":"Gallardo","year":"2015","journal-title":"Porcine Health Manage"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0025","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/tbed.14183","article-title":"One hundred years of African swine fever: a tribute to R. Eustace Montgomery","volume":"68","author":"Penrith","year":"2021","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/jsava.v84i1.1106","article-title":"History of\u2019swine fever\u2019in southern Africa: historical article","volume":"84","author":"Penrith","year":"2013","journal-title":"J S Afr Vet Assoc"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127243_bb0035","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1099\/0022-1317-79-6-1439","article-title":"The pathogenesis of African swine fever in the resistant bushpig","volume":"79","author":"Oura","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127243_bb0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fvets.2020.00215","article-title":"African swine fever virus: an emerging DNA arbovirus","volume":"7","author":"Gaudreault","year":"2020","journal-title":"Front Veterinary Sci"},{"issue":"1530","key":"10.1016\/j.vaccine.2025.127243_bb0045","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1098\/rstb.2009.0098","article-title":"African swine fever: how can global spread be prevented?","volume":"364","author":"Costard","year":"2009","journal-title":"Philoso Trans Roy Soc B: Biol Sci"},{"key":"10.1016\/j.vaccine.2025.127243_bb0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fvets.2020.00282","article-title":"Comparative pathology and pathogenesis of African swine fever infection in swine","volume":"7","author":"Salguero","year":"2020","journal-title":"Front Vet Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0167-5877(98)00063-4","article-title":"Temporal and spatial patterns of African swine fever in Sardinia","volume":"35","author":"Mannelli","year":"1998","journal-title":"Prev Vet Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0060","article-title":"Simultaneous deletion of the 9GL and UK genes from the African swine fever virus Georgia 2007 isolate offers increased safety and protection against homologous challenge","volume":"91","author":"O\u2019Donnell","year":"2017","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0065","doi-asserted-by":"crossref","first-page":"e1101","DOI":"10.1111\/tbed.14403","article-title":"Understanding the transmission of African swine fever in wild boars of South Korea: a simulation study for parameter estimation","volume":"69","author":"Han","year":"2022","journal-title":"Transbound Emerg Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2025.127243_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01199-21","article-title":"African swine fever virus bearing an I226R gene deletion elicits robust immunity in pigs to African swine fever","volume":"95","author":"Zhang","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127243_bb0075","author":"(WOAH), W.O.f.A.H"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127243_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/v13122552","article-title":"Prevention and control strategies of African swine fever and Progress on pig farm repopulation in China","volume":"13","author":"Liu","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127243_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tvjl.2017.12.025","article-title":"African swine fever: a re-emerging viral disease threatening the global pig industry","volume":"233","author":"S\u00e1nchez-Cord\u00f3n","year":"2018","journal-title":"Vet J"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2375550","article-title":"Pathogenicity and virulence of African swine fever virus","volume":"15","author":"Ruedas-Torres","year":"2024","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/pathogens9040274","article-title":"Protective properties of attenuated strains of African swine fever virus belonging to seroimmunotypes I\u2013VIII","volume":"9","author":"Sereda","year":"2020","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127243_bb0100","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/life12081255","article-title":"African swine fever virus: a review","volume":"12","author":"Li","year":"2022","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127243_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/vaccines10030344","article-title":"Immune escape mechanism and vaccine research progress of African swine fever virus","volume":"10","author":"Wang","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41541-024-00845-9","article-title":"Recent progress on gene-deleted live-attenuated African swine fever virus vaccines","volume":"9","author":"Vu","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.127243_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.105024","article-title":"Research progress on live attenuated vaccine against African swine fever virus","volume":"158","author":"Liu","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2025.127243_bb0120","series-title":"Recombinant ASF live attenuated virus strains as experimental vaccine candidates","author":"Gladue","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127243_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198099","article-title":"African swine fever \u2013 a review of current knowledge","volume":"287","author":"Blome","year":"2020","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0130","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.2020.21.e38","article-title":"African swine fever: etiology, epidemiological status in Korea, and perspective on control","volume":"21","author":"Yoo","year":"2020","journal-title":"J Vet Sci"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127243_bb0135","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/v13071212","article-title":"African swine fever virus as a difficult opponent in the fight for a vaccine\u2014current data","volume":"13","author":"Turlewicz-Podbielska","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.virusres.2012.12.018","article-title":"Standardization of pathological investigations in the framework of experimental ASFV infections","volume":"173","author":"Galindo-Cardiel","year":"2013","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127243_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2020.108832","article-title":"Multifaceted immune responses to African swine fever virus: implications for vaccine development","volume":"249","author":"Wang","year":"2020","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/vaccines5040035","article-title":"Approaches and perspectives for development of African swine fever virus vaccines","volume":"5","author":"Arias","year":"2017","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127243_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40813-020-00154-2","article-title":"African swine fever vaccines: a promising work still in progress","volume":"6","author":"Bosch-Cam\u00f3s","year":"2020","journal-title":"Porcine Health Manage"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127243_bb0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/vaccines8030531","article-title":"Current state of global African swine fever vaccine development under the prevalence and transmission of ASF in China","volume":"8","author":"Wu","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127243_bb0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fvets.2020.00084","article-title":"Progress toward development of effective and safe African swine fever virus vaccines","volume":"7","author":"Sang","year":"2020","journal-title":"Front Veterinary Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127243_bb0170","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3390\/v14122619","article-title":"African swine fever modified live vaccine candidates: transitioning from discovery to product development through harmonized standards and guidelines","volume":"14","author":"Brake","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127243_bb0175","article-title":"Vaccines for African swine fever: an update","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127243_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.56808\/2985-1130.3186","article-title":"African swine fever vaccine development: current status and challenges ahead","volume":"52","author":"Monoldorova","year":"2022","journal-title":"Thai J Veterinary Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0185","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/vaccines11040762","article-title":"Summary of the current status of African swine fever vaccine development in China","volume":"11","author":"Han","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/tbed.13364","article-title":"Current status and evolving approaches to African swine fever vaccine development","volume":"67","author":"Teklue","year":"2020","journal-title":"Transbound Emerg Dis"},{"issue":"06","key":"10.1016\/j.vaccine.2025.127243_bb0195","first-page":"83","article-title":"Current efforts towards safe and effective live attenuated vaccines against African swine fever: challenges and prospects","volume":"10","author":"Wang","year":"2021","journal-title":"Infect Dis Poverty"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127243_bb0200","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3168\/jds.2009-2140","article-title":"Invited review: use of meta-analysis in animal health and reproduction: methods and applications","volume":"92","author":"Lean","year":"2009","journal-title":"J Dairy Sci"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127243_bb0205","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/ani12162136","article-title":"Evidence-based approaches for determining effective target antigens to develop vaccines against post-weaning diarrhea caused by enterotoxigenic Escherichia coli in pigs: a systematic review and network meta-analysis","volume":"12","author":"Ntakiyisumba","year":"2022","journal-title":"Animals"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127243_bb0210","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.vaccine.2022.02.021","article-title":"Efficacy of commercially available vaccines against canine leptospirosis: a systematic review and meta-analysis","volume":"40","author":"Esteves","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0215","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1038\/s41598-022-10439-x","article-title":"Systematic review and network meta-analysis to compare vaccine effectiveness against porcine edema disease caused by Shiga toxin-producing Escherichia coli","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/fpd.2017.2417","article-title":"A meta-analysis of major foodborne pathogens in Chinese food commodities between 2006 and 2016","volume":"15","author":"Paudyal","year":"2018","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.vaccine.2025.127243_bb0225","first-page":"372","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","author":"Page","year":"2021","journal-title":"bmj"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127243_bb0230","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/tbed.12431","article-title":"Experimental transmission of African swine fever (ASF) low virulent isolate NH\/P68 by surviving pigs","volume":"62","author":"Gallardo","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127243_bb0235","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0240","first-page":"153","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.vaccine.2025.127243_bb0245","series-title":"Doing meta-analysis with R: A hands-on guide","author":"Harrer","year":"2021"},{"key":"10.1016\/j.vaccine.2025.127243_bb0250","series-title":"R: A language and environment for statistical computing","author":"Team","year":"2013"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127243_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0260","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/tbed.14259","article-title":"Efficacy of Brucella abortus S19 and RB51 vaccine strains: a systematic review and meta-analysis","volume":"69","author":"de Oliveira","year":"2022","journal-title":"Transbound Emerg Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127243_bb0265","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/oxfordjournals.aje.a009523","article-title":"Confidence limits made easy: interval estimation using a substitution method","volume":"147","author":"Daly","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0270","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.6028\/jres.087.022","article-title":"Consensus values and weighting factors","volume":"87","author":"Paule","year":"1982","journal-title":"J Res Natl Bur Stand"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127243_bb0280","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209760","article-title":"Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma","volume":"14","author":"Sabarimurugan","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127243_bb0290","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1128\/JVI.00554-15","article-title":"African swine fever virus Georgia isolate harboring deletions of MGF360 and MGF505 genes is attenuated in swine and confers protection against challenge with virulent parental virus","volume":"89","author":"O\u2019Donnell","year":"2015","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2025.127243_bb0295","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1128\/JVI.00969-15","article-title":"African swine fever virus Georgia 2007 with a deletion of virulence-associated gene 9GL (B119L), when administered at low doses, leads to virus attenuation in swine and induces an effective protection against homologous challenge","volume":"89","author":"O\u2019Donnell","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127243_bb0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2016.05.014","article-title":"African swine fever virus Georgia isolate harboring deletions of 9GL and MGF360\/505 genes is highly attenuated in swine but does not confer protection against parental virus challenge","volume":"221","author":"O'Donnell","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127243_bb0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2015.12.002","article-title":"Deletion of the thymidine kinase gene induces complete attenuation of the Georgia isolate of African swine fever virus","volume":"213","author":"Sanford","year":"2016","journal-title":"Virus Res"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127243_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02017-19","article-title":"Development of a highly effective African swine fever virus vaccine by deletion of the I177L gene results in sterile immunity against the current epidemic Eurasia strain","volume":"94","author":"Borca","year":"2020","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127243_bb0315","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00123-21","article-title":"A cell culture-adapted vaccine virus against the current African swine fever virus pandemic strain","volume":"95","author":"Borca","year":"2021","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/v13050765","article-title":"ASFV-G-\u2206I177L as an effective Oral nasal vaccine against the Eurasia strain of Africa swine fever","volume":"13","author":"Borca","year":"2021","journal-title":"Viruses"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127243_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00545-22","article-title":"Deletion of the H108R gene reduces virulence of the pandemic Eurasia strain of African swine fever virus with surviving animals being protected against virulent challenge","volume":"96","author":"Vuono","year":"2022","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127243_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/v14122777","article-title":"Oronasal or intramuscular immunization with a Thermo-attenuated ASFV strain provides full clinical protection against Georgia 2007\/1 challenge","volume":"14","author":"Bourry","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127243_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11090996","article-title":"Taking a promising vaccine candidate further: efficacy of ASFV-G-DeltaMGF after intramuscular vaccination of domestic pigs and Oral vaccination of wild boar","volume":"11","author":"Deutschmann","year":"2022","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0340","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1111\/tbed.14329","article-title":"African swine fever virus vaccine candidate ASFV-G-DeltaI177L efficiently protects European and native pig breeds against circulating Vietnamese field strain","volume":"69","author":"Tran","year":"2022","journal-title":"Transbound Emerg Dis"},{"issue":"39","key":"10.1016\/j.vaccine.2025.127243_bb0345","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1016\/j.vaccine.2016.08.011","article-title":"Deletion of African swine fever virus interferon inhibitors from the genome of a virulent isolate reduces virulence in domestic pigs and induces a protective response","volume":"34","author":"Reis","year":"2016","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2025.127243_bb0350","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01428-17","article-title":"Deletion of the African swine fever virus gene DP148R does not reduce virus replication in culture but reduces virus virulence in pigs and induces high levels of protection against challenge","volume":"91","author":"Reis","year":"2017","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0355","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.vaccine.2017.12.030","article-title":"Evaluation of protection induced by immunisation of domestic pigs with deletion mutant African swine fever virus BeninDeltaMGF by different doses and routes","volume":"36","author":"Sanchez-Cordon","year":"2018","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127243_bb0360","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00350-20","article-title":"Absence of long-term protection in domestic pigs immunized with attenuated African swine fever virus isolate OURT88\/3 or BeninDeltaMGF correlates with increased levels of regulatory T cells and Interleukin-10","volume":"94","author":"Sanchez-Cordon","year":"2020","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0365","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01340-21","article-title":"Role of African swine fever virus proteins EP153R and EP402R in reducing viral persistence in blood and virulence in pigs infected with BeninDeltaDP148R","volume":"96","author":"Petrovan","year":"2022","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0370","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11427-020-1657-9","article-title":"A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs","volume":"63","author":"Chen","year":"2020","journal-title":"Sci China Life Sci"},{"issue":"21","key":"10.1016\/j.vaccine.2025.127243_bb0375","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01058-17","article-title":"BA71DeltaCD2: a new recombinant live attenuated African swine fever virus with cross-protective capabilities","volume":"91","author":"Monteagudo","year":"2017","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127243_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/v12121474","article-title":"Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in cross-protection","volume":"12","author":"Lopez","year":"2020","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127243_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/v13091678","article-title":"Deletion mutants of the attenuated recombinant ASF virus, BA71DeltaCD2, show decreased vaccine efficacy","volume":"13","author":"Lopez","year":"2021","journal-title":"Viruses"},{"issue":"28","key":"10.1016\/j.vaccine.2025.127243_bb0390","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.vaccine.2011.04.052","article-title":"Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation","volume":"29","author":"King","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2013.04.028","article-title":"Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88\/3 decreases its ability to protect against challenge with virulent virus","volume":"443","author":"Abrams","year":"2013","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0400","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1111\/tbed.12303","article-title":"Immunization of African indigenous pigs with attenuated genotype I African swine fever virus OURT88\/3 induces protection against challenge with virulent strains of genotype I","volume":"63","author":"Mulumba-Mfumu","year":"2016","journal-title":"Transbound Emerg Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0405","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/tbed.12250","article-title":"Vaccine potential of two previously uncharacterized African swine fever virus isolates from southern Africa and heterologous cross protection of an Avirulent European isolate","volume":"63","author":"Souto","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2025.127243_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.11.021","article-title":"Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88\/3","volume":"138","author":"Sanchez-Cordon","year":"2017","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0415","article-title":"Deletion of the gene for the type I interferon inhibitor I329L from the attenuated African swine fever virus OURT88\/3 strain reduces protection induced in pigs","volume":"8","author":"Reis","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0420","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/vaccines8040763","article-title":"Generation and evaluation of an African swine fever virus mutant with deletion of the CD2v and UK genes","volume":"8","author":"Teklue","year":"2020","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/v13020255","article-title":"Deletion of the L7L-L11L genes attenuates ASFV and induces protection against homologous challenge","volume":"13","author":"Zhang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127243_bb0430","doi-asserted-by":"crossref","first-page":"1225469","DOI":"10.3389\/fmicb.2023.1225469","article-title":"SY18DeltaL60L: a new recombinant live attenuated African swine fever virus with protection against homologous challenge","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127243_bb0435","article-title":"Recombinant African swine fever virus arm\/07\/CBM\/c2 lacking CD2v and A238L is attenuated and protects pigs against virulent Korean Paju strain","volume":"10","author":"Perez-Nunez","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/v15020311","article-title":"A spontaneously occurring African swine fever virus with 11 gene deletions partially protects pigs challenged with the parental strain","volume":"15","author":"Kitamura","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127243_bb0445","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1099\/jgv.0.000490","article-title":"African swine fever virus serotype-specific proteins are significant protective antigens for African swine fever","volume":"97","author":"Burmakina","year":"2016","journal-title":"J Gen Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127243_bb0450","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1007\/s00705-017-3471-5","article-title":"Virulent strain of African swine fever virus eclipses its attenuated derivative after challenge","volume":"162","author":"Titov","year":"2017","journal-title":"Arch Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127243_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/v11070599","article-title":"Differential effect of the deletion of African swine fever virus virulence-associated genes in the induction of attenuation of the highly virulent Georgia strain","volume":"11","author":"Ramirez-Medina","year":"2019","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127243_bb0460","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/v12101185","article-title":"Deletion of CD2-like (CD2v) and C-type lectin-like (EP153R) genes from African swine fever virus Georgia-\u22069GL abrogates its effectiveness as an experimental vaccine","volume":"12","author":"Gladue","year":"2020","journal-title":"Viruses"},{"issue":"21","key":"10.1016\/j.vaccine.2025.127243_bb0465","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01139-21","article-title":"Deletion of the A137R gene from the pandemic strain of African swine fever virus attenuates the strain and offers protection against the virulent pandemic virus","volume":"95","author":"Gladue","year":"2021","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01419-21","article-title":"Deletion of E184L, a putative DIVA target from the pandemic strain of African swine fever virus, produces a reduction in virulence and protection against virulent challenge","volume":"96","author":"Ramirez-Medina","year":"2022","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127243_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/v14051112","article-title":"Deletion of African swine fever virus histone-like protein, A104R from the Georgia isolate drastically reduces virus virulence in domestic pigs","volume":"14","author":"Ramirez-Medina","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127243_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.902932","article-title":"Protection evaluation of a five-gene-deleted African swine fever virus vaccine candidate against homologous challenge","volume":"13","author":"Xie","year":"2022","journal-title":"Front Microbiol"},{"issue":"15","key":"10.1016\/j.vaccine.2025.127243_bb0485","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210808120","article-title":"African swine fever virus I73R is a critical virulence-related gene: a potential target for attenuation","volume":"120","author":"Liu","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0490","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2148560","article-title":"Evaluation of an I177L gene-based five-gene-deleted African swine fever virus as a live attenuated vaccine in pigs","volume":"12","author":"Liu","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127243_bb0495","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.vaccine.2018.03.040","article-title":"African swine fever virus (ASFV) protection mediated by NH\/P68 and NH\/P68 recombinant live-attenuated viruses","volume":"36","author":"Gallardo","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0500","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/viro.1998.9068","article-title":"The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response","volume":"243","author":"Gomez-Puertas","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127243_bb0505","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13567-015-0275-z","article-title":"Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in viral pathogenesis and immune protection","volume":"46","author":"Lacasta","year":"2015","journal-title":"Vet Res"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127243_bb0510","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00329-22","article-title":"Combinational deletions of MGF360-9L and MGF505-7R attenuated highly virulent African swine fever virus and conferred protection against homologous challenge","volume":"96","author":"Ding","year":"2022","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127243_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104767","article-title":"Deletions of MGF110-9L and MGF360-9L from African swine fever virus are highly attenuated in swine and confer protection against homologous challenge","volume":"299","author":"Li","year":"2023","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127243_bb0520","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00247-23","article-title":"Deletion of DP148R, DP71L, and DP96R attenuates African swine fever virus, and the mutant strain confers complete protection against homologous challenges in pigs","volume":"97","author":"Qi","year":"2023","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127243_bb0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270641","article-title":"The attenuated ASFV strains MK-200 and FK-32\/135 as possible models for investigation of protective immunity by ASFV infection","volume":"17","author":"Sereda","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127243_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/v14081630","article-title":"Immunobiological characteristics of the attenuated African swine fever virus strain Katanga-350","volume":"14","author":"Sereda","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/v15020430","article-title":"Inoculation with ASFV-Katanga-350 partially protects pigs from death during subsequent infection with heterologous type ASFV-Stavropol 01\/08","volume":"15","author":"Vlasov","year":"2023","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127243_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/v14092024","article-title":"Co-deletion of A238L and EP402R genes from a genotype IX African swine fever virus results in partial attenuation and protection in swine","volume":"14","author":"Abkallo","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127243_bb0545","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/v14091917","article-title":"Deletion of the CD2v gene from the genome of ASFV-Kenya-IX-1033 partially reduces virulence and induces protection in pigs","volume":"14","author":"Hemmink","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0550","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.virol.2003.11.011","article-title":"Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection","volume":"319","author":"Neilan","year":"2004","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2025.127243_bb0555","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1099\/vir.0.81038-0","article-title":"In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus","volume":"86","author":"Oura","year":"2005","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127243_bb0560","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2012.10.012","article-title":"Antibody-mediated neutralization of African swine fever virus: myths and facts","volume":"173","author":"Escribano","year":"2013","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0565","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/tbed.13117","article-title":"Epidemiology of African swine fever in Africa today: sylvatic cycle versus socio-economic imperatives","volume":"66","author":"Penrith","year":"2019","journal-title":"Transbound Emerg Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127243_bb0570","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1099\/vir.0.83343-0","article-title":"Comparison of the genome sequences of non-pathogenic and pathogenic African swine fever virus isolates","volume":"89","author":"Chapman","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127243_bb0575","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virusres.2019.03.022","article-title":"Development of vaccines against African swine fever virus","volume":"265","author":"S\u00e1nchez","year":"2019","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25005407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25005407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:42:56Z","timestamp":1762278176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25005407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":115,"alternative-id":["S0264410X25005407"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127243","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive analysis of the current strategy for developing live attenuated vaccines against African swine fever: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127243"}}